a2z Radiology AI vs ETRADE

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

ETRADE

EmergingFinance

Neobanking and Neobrokerage

Morgan Stanley-owned (MS, $13B acquisition 2020) online brokerage with commission-free trading and advanced options platform; competing with Fidelity, Schwab, and Robinhood for retail investor brokerage.

AI VisibilityBeta
Overall Score
D20
Category Rank
#3 of 4
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
19
Perplexity
15
Gemini
28

About

E*TRADE is a Morgan Stanley-owned online brokerage and financial services platform providing self-directed investors with commission-free stock and ETF trading, options and futures trading, retirement accounts (IRAs, Roth IRAs), managed portfolios, and banking services through web and mobile platforms. Founded in 1982 in Menlo Park and one of the pioneers of retail online trading, E*TRADE was acquired by Morgan Stanley (NYSE: MS) for $13 billion in October 2020, integrating E*TRADE's retail brokerage with Morgan Stanley's wealth management business.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.